Indraprastha Medical board to review half-yearly financial results

Indraprastha Medical Corporation Limited announced an upcoming board of directors meeting scheduled for Saturday, November 1, 2025. The primary agenda for this meeting is to consider and approve the unaudited financial results for the quarter and half-year that concluded on September 30, 2025. This disclosure was made in compliance with Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The announcement, dated October 17, 2025, was communicated to both BSE Limited and the National Stock Exchange of India Limited. For BSE, the company's scrip code is 532150, while on the National Stock Exchange, the symbol is INDRAMEDCO. The company's registered office is located in Sarita Vihar, Delhi-Mathura Road, New Delhi – 110 076.

The letter was signed by Priya Ranjan, avp – corporate affairs & legal (company secretary & compliance officer), signifying the official nature of the communication to regulatory bodies and the public.